文献速递青光眼眼底病与葡萄膜炎

慢性青光眼大鼠模型中视网膜神经节细胞最耐受与最脆弱亚型的特征分析

Characterization of the Most Resistant and Vulnerable Retinal Ganglion Cell Subtypes in a Chronic Model of Glaucoma in Rat.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2025-01-01

研究在大鼠慢性青光眼模型(巩膜外静脉烧灼)中分析视网膜神经节细胞(RGC)亚型的差异性丢失。结果显示OPN4阳性RGC(ipRGC)比例升高提示更耐受,CART阳性RGC(ooDSGC)比例显著下降提示高度脆弱;SPP1、Foxp2、Islet1/2、Tbr2阳性RGC比例不变,提示与总体RGC减少成比例丢失。

要点

  • 慢性青光眼大鼠模型中,RGC存活率在视网膜周边部下降,背鼻侧为65.44%、腹颞侧为76.03%。
  • CART阳性RGC(ooDSGC)比例下降,背鼻侧由32.9%±5.15%降至20.26%±2.64%,腹颞侧由33.07%±4.09%降至22.65%±2.65%。
  • OPN4阳性RGC(ipRGC)背鼻侧比例由3.27%±1.34%升至6.99%±2.31%,提示其更耐受。

核心结论

  • RGC亚型对眼压升高的易感性不同,OPN4阳性RGC(ipRGC)更耐受,CART阳性RGC(ooDSGC)高度脆弱。
  • 作者认为需研究ooDSGC变性并探索靶向神经保护,未来研究应开发保护、再生或替代ooDSGC的治疗。

研究设计与样本

  • 研究采用大鼠慢性青光眼模型,通过烧灼三支巩膜外静脉建立。
  • 使用压平眼压计测量眼压,40天后处死动物,取全视网膜铺片进行免疫染色。
  • RGC以抗RBPMS抗体标记(标记100%的RGC),并与CART、OPN4、Foxp2、Islet1/2、SPP1、Tbr2亚型特异性抗体共标记。
  • RGC丢失和亚型分布以RBPMS阳性细胞的百分比在不同视网膜区域进行定量。

主要发现

  • 青光眼眼中RGC存活率在视网膜周边部下降,背鼻侧为65.44%,腹颞侧为76.03%。
  • CART阳性RGC比例在背鼻侧由32.9%±5.15%降至20.26%±2.64%,在腹颞侧由33.07%±4.09%降至22.65%±2.65%,表明其更高脆弱性。
  • OPN4阳性RGC比例在背鼻侧由3.27%±1.34%升至6.99%±2.31%,提示内在光敏性RGC(ipRGC)更耐受。
  • SPP1、Foxp2、Islet1/2和Tbr2阳性RGC的百分比保持不变,提示与总体RGC减少成比例丢失。

关键数值与推荐

  • RGC存活率:背鼻侧65.44%,腹颞侧76.03%(以RBPMS阳性细胞百分比计)。
  • CART阳性RGC比例:背鼻侧32.9%±5.15%降至20.26%±2.64%,腹颞侧33.07%±4.09%降至22.65%±2.65%。
  • OPN4阳性RGC比例:背鼻侧3.27%±1.34%升至6.99%±2.31%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Retinal ganglion cells (RGCs) transmit visual information to the brain and are selectively affected in glaucoma, a neurodegenerative disease caused by increased intraocular pressure (IOP) leading to vision loss. Not all RGC subtypes are equally vulnerable; thus, this study aimed to comprehensively analyze the differential loss of RGC subtypes using a rat model of chronic glaucoma. METHODS: A chronic glaucoma model was established by cauterizing three episcleral veins in rat eyes. IOP was measured using an applanation tonometer, and after 40 days animals were euthanized. Whole-mount retinas were immunostained. RGCs were labeled with anti-RNA-binding protein with multiple splicing (RBPMS; marks 100% of RGCs) and co-labeled with subtype-specific antibodies: CART, melanopsin (OPN4), Foxp2, Islet1/2, SPP1, and Tbr2. RGC loss and subtype distribution were quantified as percentages of RBPMS-positive cells in different retinal regions. RESULTS: In glaucomatous eyes, RGC survival decreased in the retinal periphery, with 65.44% in the dorsal-nasal and 76.03% in the ventral-temporal regions. CART-positive RGCs dropped from 32.9% ± 5.15% to 20.26% ± 2.64% (dorsal-nasal) and from 33.07% ± 4.09% to 22.65% ± 2.65% (ventral-temporal), indicating higher vulnerability. In contrast, OPN4-positive RGCs increased from 3.27% ± 1.34% to 6.99% ± 2.31% (dorsal-nasal), suggesting greater intrinsically photosensitive RGC (ipRGC) resilience. Percentages of SPP1-, Foxp2-, Islet1/2-, and Tbr2-positive RGCs remained unchanged, suggesting proportional loss to total RGC reduction. CONCLUSIONS: RGC subtypes showed differing susceptibilities to IOP, with OPN4-positive RGCs (ipRGCs) being more resistant and CART-positive RGCs (ON-OFF direction-selective ganglion cells [ooDSGCs]) highly vulnerable. This highlights the need to study ooDSGC degeneration and explore targeted neuroprotection. Future research should develop therapies to protect, regenerate, or replace ooDSGCs.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Ruzafa N, Pereiro X, Prieto-López L, et al. Characterization of the Most Resistant and Vulnerable Retinal Ganglion Cell Subtypes in a Chronic Model of Glaucoma in Rat. Invest Ophthalmol Vis Sci. 2025. PMID: 41031737. doi:10.1167/iovs.66.13.5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。